Verifying…
Home / Registered in Nigeria / Montral Tablets

Montral Tablets

NAFDAC Reg. No. B4-6888 · Drug

Registered with NAFDAC. Registration activeAs of 29 October 2026 · synced automatically from official sources.
Product
Montral Tablets
NAFDAC number
B4-6888
Active ingredient
Montelukast (Montelukast Sodium); Levocetirizine Dihydrochloride
Strength
10 mg; 5 mg
Form
Tablet
Pack size
1 x 10's (in blister)
Manufacturer
Not listed
Applicant (holder)
Micro Nova Pharmaceuticals Ind Ltd
Approved
26 Apr 2023
Status
Active View on NAFDAC ↗
Registration valid to
25 Apr 2028
WHO alerts
None found
Community reports
None
Times checked
0

About the medicine: Montelukast: uses, dosage and brands worldwide

What we found

  • Montral Tablets is on the NAFDAC register with an active registration (B4-6888). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Montral Tablets

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

How to take it and how often
  • Adults 65 years of age and older ask a doctor
  • Adults and children 12-64 years of age take 1 tablet (5 mg) once daily in the evening
  • Do not take more than 1 tablet (5 mg) in 24 hours 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
  • Children 6-11 years of age take 1/2 tablet (2.5 mg) once daily in the evening
  • Do not take more than 1/2 tablet (2.5 mg) in 24 hours
  • Children under 6 years of age do not use consumers with kidney disease do not use
While you are taking it

drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery

Talk to a doctor first if

ever had trouble urinating or emptying your bladder

Warnings

Do not use if you have kidney disease if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine Ask a doctor before use if you have ever had trouble urinating or emptying your bladder When using this product drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery Stop use and ask doctor if you have trouble urinating or emptying your bladder an allergic reaction to this product occurs. Seek medical help right away. …

Possible side effects

Stop use and ask doctor if you have trouble urinating or emptying your bladder an allergic reaction to this product occurs. Seek medical help right away.

Pregnancy and breastfeeding

If pregnant or breast-feeding: if breast-feeding: not recommended if pregnant: ask a health professional before use

How to store it

Keep out of reach of children.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-12-10.

Label for montelukast (montelukast sodium) and levocetirizine dihydrochloride, the active ingredient registered with NAFDAC.

Check your pack of Montral Tablets

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Montral Tablets

What is in Montral Tablets?

Montral Tablets contains Montelukast (Montelukast Sodium); Levocetirizine Dihydrochloride (10 mg; 5 mg), as tablet, according to its NAFDAC registration record.

Is Montral Tablets registered with NAFDAC?

Yes. Montral Tablets is listed on the NAFDAC register under registration number B4-6888, and its registration is active as of 29 October 2026.

Has Montral Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Montral Tablets in our automatically synced alert list.

How can I check that my pack of Montral Tablets is genuine?

Run a free authenticity scan with the NAFDAC number B4-6888, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Montral Tablets?

Follow your prescription or the leaflet in your pack. The official label says: adults 65 years of age and older ask a doctor adults and children 12-64 years of age take 1 tablet (5 mg) once daily in the evening do not take more than 1 tablet (5 mg) in 24 hours 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms children 6-11 years of age take 1/2 tablet (2.5 mg) once daily in the evening do not take more than 1/2 tabl…

What is Montral Tablets used for?

temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat (Summarised from the official U.S. FDA label for montelukast (montelukast sodium) and levocetirizine dihydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Montral Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.